Search research articles
Contact Us
Filters
Showing results (51-60 of 215) with videos related to
Page
of 22
Sort By:
European Journal of Immunology
|
July 21, 2006
Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area
Philip Bejon, Oscar K Kai, Jedidah Mwacharo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 9, 2013
Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
Richard D Antrobus, Tamara K Berthoud, Caitlin E Mullarkey, et al.
The Journal of Infectious Diseases
|
January 19, 2005
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites
Philip Bejon, Laura Andrews, Rikke F Andersen, et al.
Travel Medicine and Infectious Disease
|
April 26, 2012
Distinguishing malaria and influenza: early clinical features in controlled human experimental infection studies
Patrick J Lillie, Christopher J A Duncan, Susanne H Sheehy, et al.
Immunology
|
June 16, 2004
Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin
H Martin Vordermeier, Shelley G Rhodes, Gillian Dean, et al.
Infection and Immunity
|
October 28, 2009
Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
Arturo Reyes-Sandoval, Tamara Berthoud, Nicola Alder, et al.
Genome Medicine
|
March 16, 2021
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription
Abdulaziz Almuqrin, Andrew D Davidson, Maia Kavanagh Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 2006
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya
Philip Bejon, Norbert Peshu, Sarah C Gilbert, et al.
Plos One
|
August 22, 2007
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
Philip Bejon, Edna Ogada, Tabitha Mwangi, et al.
Nature Medicine
|
October 27, 2004
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
Helen McShane, Ansar A Pathan, Clare R Sander, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 215) with videos related to
Sort By:
Page
of 22
European Journal of Immunology
|
July 21, 2006
Alternating vector immunizations encoding pre-erythrocytic malaria antigens enhance memory responses in a malaria endemic area
Philip Bejon, Oscar K Kai, Jedidah Mwacharo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 9, 2013
Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
Richard D Antrobus, Tamara K Berthoud, Caitlin E Mullarkey, et al.
The Journal of Infectious Diseases
|
January 19, 2005
Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites
Philip Bejon, Laura Andrews, Rikke F Andersen, et al.
Travel Medicine and Infectious Disease
|
April 26, 2012
Distinguishing malaria and influenza: early clinical features in controlled human experimental infection studies
Patrick J Lillie, Christopher J A Duncan, Susanne H Sheehy, et al.
Immunology
|
June 16, 2004
Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin
H Martin Vordermeier, Shelley G Rhodes, Gillian Dean, et al.
Infection and Immunity
|
October 28, 2009
Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses
Arturo Reyes-Sandoval, Tamara Berthoud, Nicola Alder, et al.
Genome Medicine
|
March 16, 2021
SARS-CoV-2 vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals low levels of viral backbone gene transcription alongside very high levels of SARS-CoV-2 S glycoprotein gene transcription
Abdulaziz Almuqrin, Andrew D Davidson, Maia Kavanagh Williamson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 2006
Safety profile of the viral vectors of attenuated fowlpox strain FP9 and modified vaccinia virus Ankara recombinant for either of 2 preerythrocytic malaria antigens, ME-TRAP or the circumsporozoite protein, in children and adults in Kenya
Philip Bejon, Norbert Peshu, Sarah C Gilbert, et al.
Plos One
|
August 22, 2007
Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya
Philip Bejon, Edna Ogada, Tabitha Mwangi, et al.
Nature Medicine
|
October 27, 2004
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans
Helen McShane, Ansar A Pathan, Clare R Sander, et al.
Page
of 22